AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

XORTX Therapeutics Inc.

CAD 3.19 -$16.81 (-84.05%)
TSXV · 31 Aug 2026 19:55 UTC
Previous Close
CAD 3.19
Day Range
CAD 3.19CAD 3.2
Year Range
CAD 2.42CAD 9.85
Market Cap
888.38K
AVG Volume
1.15K
Trailing/Forward PE
-0.32/0.79
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-12
Primary Exchange
Toronto Stock Exchange VenturesCA
Net Income (USD) · TTM
-4M-3M-2M-1M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-3.68M
26 Q1-2.75M
25 Q4-2.66M
25 Q3-1.94M
25 Q2-1.88M
25 Q1-993.08K
24 Q4-3.31M
24 Q3-736.66K
24 Q2-1.48M
24 Q1-3.34M
Operating Income (USD) · TTM
-8M-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-3.86M
26 Q1-3.1M
25 Q4-3.26M
25 Q3-3.22M
25 Q2-3.39M
25 Q1-5.62M
24 Q4-5.75M
24 Q3-6.07M
24 Q2-6.59M
24 Q1-5.22M
EBITDA (USD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-3.69M
26 Q1-2.93M
25 Q4-3.08M
25 Q3-3.05M
25 Q2-3.28M
25 Q1-3.88M
24 Q4-4M
24 Q3-4.33M
24 Q2-4.85M
24 Q1-5.12M
Cash Flows (USD) · TTM
-6M-4M-2M024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-1.84M
26 Q1-2.65M
25 Q4-2.8M
25 Q3-2.97M
25 Q2-3.13M
25 Q1-3.06M
24 Q4-3.72M
24 Q3-4.13M
24 Q2-4.44M
24 Q1-5.43M
EPS (USD) · TTM
-40-30-20-10024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-7.21
26 Q1-10.94
25 Q4-15.12
25 Q3-11.82
25 Q2-13.57
25 Q1-7.07
24 Q4-33.32
24 Q3-3.75
24 Q2-15.5
24 Q1-38.5
Expenses (USD) · TTM
-4M-2M02M4MR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2-3.62K
26 Q12.21M
25 Q42.81M
25 Q32.54M
25 Q22.46M
25 Q12.69M
24 Q42.52M
24 Q32.73M
24 Q23.23M
24 Q13.71M
Shares Outstanding · TTM
-200K-150K-100K-50K024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
XRTX.V Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
26 Q2-17.06K
26 Q1-24K
25 Q4-25.16K
25 Q3-30.54K
25 Q2-41.28K
25 Q1-78.36K
24 Q4-141.37K
24 Q3-160.68K
24 Q2-174.5K
24 Q1-171.22K
PE Ratio
22.533.54med 2.69Dec 22Jan 23Jan 23Feb 23Feb 23Mar 23Mar 23
XRTX.V PE Ratio by quarter
PeriodPE Ratio
Mar 232.14
Mar 232.23
Mar 232.4
Mar 232.73
Feb 232.56
Feb 232.69
Feb 232.69
Feb 232.66
Jan 232.69
Jan 233.32
Jan 233.61
Jan 233.22
Dec 223.68
Free Cash Flow Yield
-600%-400%-200%0%med -115.7%Dec 24Mar 25Jul 25Oct 25Feb 26May 26Sep 26
XRTX.V Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-83.03%
Aug 26-86.88%
Aug 26-92.05%
Aug 26-95.12%
Aug 26-94.87%
Jul 26-94.05%
Jul 26-91.06%
Jul 26-90.59%
Jul 26-93.66%
Jul 26-92.74%
Jun 26-515.95%
Jun 26-497.53%
Jun 26-465.75%
Jun 26-512.09%
May 26-464.88%
May 26-482.62%
May 26-413.7%
May 26-385.46%
May 26-383.97%
Apr 26-373.35%
Apr 26-487.81%
Apr 26-431.16%
Apr 26-98.86%
Mar 26-166.77%
Mar 26-131.25%
Mar 26-164.73%
Mar 26-138.38%
Feb 26-146.5%
Feb 26-164.17%
Feb 26-146.24%
Feb 26-144.32%
Jan 26-120.83%
Jan 26-108.92%
Jan 26-105.18%
Jan 26-106.47%
Jan 26-105.07%
Dec 25-103.34%
Dec 25-99.38%
Dec 25-99.19%
Dec 25-99.52%
Nov 25-100.64%
Nov 25-110.66%
Nov 25-148.39%
Nov 25-148.67%
Oct 25-128.45%
Oct 25-126.96%
Oct 25-77.16%
Oct 25-92.45%
Oct 25-104.67%
Sep 25-105.61%
Sep 25-101.53%
Sep 25-99.37%
Sep 25-105.72%
Aug 25-101.28%
Aug 25-99.2%
Aug 25-98.3%
Aug 25-100.49%
Aug 25-112.82%
Jul 25-112.09%
Jul 25-87.7%
Jul 25-86.81%
Jul 25-89.73%
Jun 25-119.16%
Jun 25-130.79%
Jun 25-124.06%
Jun 25-126.1%
May 25-122.51%
May 25-117.77%
May 25-108.99%
May 25-109.48%
May 25-112.48%
Apr 25-105.16%
Apr 25-120.51%
Apr 25-135.48%
Apr 25-124.9%
Mar 25-146.62%
Mar 25-137.14%
Mar 25-142.1%
Mar 25-144.02%
Feb 25-144.99%
Feb 25-168.69%
Feb 25-149.57%
Feb 25-162.74%
Jan 25-149.86%
Jan 25-157.07%
Jan 25-141.21%
Jan 25-110.97%
Jan 25-113.63%
Dec 24-131.09%
Dec 24-139.88%
Dec 24-128.67%
Dec 24-132.68%
Nov 24-113.21%
Nov 24-123.43%
Nov 24-110.38%
Nov 24-95.72%
Nov 24-108.18%
Oct 24-96.92%
Oct 24-78.39%
Oct 24-99.66%
EV/EBITDA
-202468med 1.77Apr 22May 22Jul 22Aug 22Sep 22Nov 22Dec 22
XRTX.V EV/EBITDA by quarter
PeriodEV/EBITDA
Dec 22-0.53
Dec 220.66
Dec 221.65
Dec 222.75
Nov 222.75
Nov 221.06
Nov 222.55
Nov 221.16
Oct 221.16
Oct 221.56
Oct 221.26
Oct 223.74
Sep 226.72
Sep 221.77
Sep 222.05
Sep 222.21
Sep 222.53
Aug 222.77
Aug 223.21
Aug 222.89
Aug 222.69
Jul 222.09
Jul 222.61
Jul 224.21
Jul 221.61
Jun 222.17
Jun 220.27
Jun 220.29
Jun 220.87
Jun 220.16
May 220.45
May 220.32
May 220.98
May 221.72
Apr 220.27
Apr 221.77
Apr 221.94
Apr 222.06
Apr 221.92
Price to Book
0123med 1.1Dec 24Mar 25Jul 25Oct 25Feb 26May 26Sep 26
XRTX.V Price to Book by quarter
PeriodPrice to Book
Sep 262.49
Aug 262.38
Aug 262.24
Aug 262.17
Aug 262.18
Jul 262.2
Jul 262.27
Jul 262.28
Jul 262.21
Jul 262.23
Jun 260.26
Jun 260.27
Jun 260.29
Jun 260.26
May 260.29
May 260.28
May 260.32
May 260.35
May 260.35
Apr 260.36
Apr 260.28
Apr 260.31
Apr 261.36
Mar 260.65
Mar 260.83
Mar 260.66
Mar 260.78
Feb 260.74
Feb 260.66
Feb 260.74
Feb 260.75
Jan 260.9
Jan 260.99
Jan 261.03
Jan 261.02
Jan 261.03
Dec 251.05
Dec 251.09
Dec 251.09
Dec 251.09
Nov 251.08
Nov 250.98
Nov 251.04
Nov 251.04
Oct 251.2
Oct 251.21
Oct 252
Oct 251.67
Oct 251.47
Sep 251.06
Sep 251.1
Sep 251.12
Sep 251.06
Aug 251.1
Aug 251.12
Aug 251.13
Aug 251.11
Aug 250.99
Jul 251
Jul 251.27
Jul 251.29
Jul 251.24
Jun 250.94
Jun 250.85
Jun 250.9
Jun 250.88
May 250.91
May 250.95
May 251.02
May 251.02
May 250.99
Apr 251.06
Apr 250.92
Apr 250.82
Apr 250.89
Mar 251.32
Mar 251.41
Mar 251.36
Mar 251.35
Feb 251.34
Feb 251.15
Feb 251.3
Feb 251.19
Jan 251.29
Jan 251.23
Jan 251.37
Jan 251.75
Jan 251.71
Dec 241.25
Dec 241.17
Dec 241.28
Dec 241.24
Nov 241.45
Nov 241.33
Nov 241.49
Nov 241.71
Nov 241.52
Oct 241.69
Oct 242.09
Oct 241.65
XORTX Therapeutics Inc.
XRTX.V
Stockpicker

Video analysis: XRTX.V

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.